Elevance Health (ELV) Operating Expenses (2009 - 2026)

Elevance Health (ELV) has 18 years of Operating Expenses data on file, last reported at $47.9 billion in Q1 2026.

• Operating Expenses for Q1 2026 came in at $47.9 billion, up 3.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $194.2 billion (up 10.61% YoY), and the FY2025 annual result was $192.4 billion, up 13.78% from the prior year.
• Operating Expenses retreated to $47.9 billion in Q1 2026 per ELV's latest filing, from $49.5 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $49.5 billion in Q4 2025 and troughed at $35.8 billion in Q1 2022.
• A 5-year average of $42.5 billion and a median of $41.2 billion in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses advanced 18.47% in 2022, then dropped 0.8% in 2024.
• A 5-year view of Operating Expenses shows it stood at $38.9 billion in 2022, then climbed by 7.1% to $41.6 billion in 2023, then rose by 7.66% to $44.8 billion in 2024, then increased by 10.47% to $49.5 billion in 2025, then fell by 3.34% to $47.9 billion in 2026.
• Business Quant data shows ELV's Operating Expenses at $47.9 billion in Q1 2026, $49.5 billion in Q4 2025, and $49.3 billion in Q3 2025.